Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04852575 · ClinicalTrials.gov registry record
ReVital-CORE Program
A clinical trial, sponsored by Kessler Foundation.
- Completed
- Registry status
- 141
- Enrollment target
NCT04852575 is a clinical trial that has completed, run by Kessler Foundation. The registered enrollment target is 141 participants.
The verdict
NCT04852575 has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- 141 participants
- Enrollment target
Study Summary
Pilot feasibility study of the ReVital Chemotherapy Online Resiliency Evaluation (CORE) program. As part of standard of care, patients starting a new chemotherapy regimen are referred to complete a pre-chemotherapy cancer rehabilitation evaluation (i.e., prehab) and invited to enroll in the ReVital-CORE program study. Once enrolled in ReVital-CORE, participants will complete a monthly online evaluation for 1 year. If frailty (or pre-frailty) is detected on any survey, physical or occupational therapy will be initiated for standard of care rehabilitation evaluation and treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2021-01-25 |
| Est. Completion | 2023-01-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04852575
The ClinicalTrials.gov registry entry for NCT04852575 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04852575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04852575 about?
NCT04852575 is a clinical study titled "ReVital-CORE Program". Pilot feasibility study of the ReVital Chemotherapy Online Resiliency Evaluation (CORE) program. As part of standard of care, patients starting a new chemotherapy regimen are referred to complete a pre-chemotherapy cancer rehabilitation evaluation (i.e., prehab) and invited to enroll in the ReVital-...
What is the current status of trial NCT04852575?
This trial is currently completed. The enrollment target is 141 participants. The study started on 2021-01-25. Estimated completion is 2023-01-25.
Who is sponsoring clinical trial NCT04852575?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.